Detalles de la búsqueda
1.
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells.
Nature
; 627(8004): 646-655, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38418879
2.
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells.
Nature
; 627(8005): E11, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38480897
3.
Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study.
Lancet Oncol
; 23(6): 781-792, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35576957
4.
A phase Ib open-label dose escalation study of the safety, pharmacokinetics, and pharmacodynamics of cobimetinib (GDC-0973) and ipatasertib (GDC-0068) in patients with locally advanced or metastatic solid tumors.
Invest New Drugs
; 39(1): 163-174, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32737717
5.
Phase I study of the anti-endothelin B receptor antibody-drug conjugate DEDN6526A in patients with metastatic or unresectable cutaneous, mucosal, or uveal melanoma.
Invest New Drugs
; 38(3): 844-854, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31385109
6.
SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer.
J Clin Oncol
; 42(3): 324-335, 2024 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37976444
7.
Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled Trial.
JAMA Oncol
; 9(11): 1574-1582, 2023 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37768658
8.
Single- and multiple-dose pharmacokinetics, potential for CYP3A inhibition, and food effect in patients with cancer and healthy subjects receiving ipatasertib.
Cancer Chemother Pharmacol
; 88(6): 921-930, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34471960
9.
A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors.
Cancer Discov
; 7(1): 102-113, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27872130
10.
A randomized controlled trial of a cardiopulmonary resuscitation video in advance care planning for progressive pancreas and hepatobiliary cancer patients.
J Palliat Med
; 16(6): 623-31, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23725233
11.
gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity.
Cancer Res
; 69(2): 573-82, 2009 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19147571
Resultados
1 -
11
de 11
1
Próxima >
>>